Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Takeda
Explore 208 clinical trials worldwide
Search
Showing 1-50 of 208 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Takeda
Clinical Trials (208)
NCT05669729
A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home Infusion
N/A
Not yet recruiting
60 participants
Started: Sep 30, 2026 · Completed: Sep 30, 2027
1 condition
1 sponsor
0 locations
NCT06579755
A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
PHASE3
Not yet recruiting
800 participants
Started: Apr 1, 2026 · Completed: Apr 14, 2027
1 condition
1 sponsor
0 locations
NCT07218393
A Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in Egypt
N/A
Not yet recruiting
100 participants
Started: Dec 1, 2025 · Completed: Dec 1, 2026
1 condition
1 sponsor
7 locations
NCT07035886
A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea
N/A
Not yet recruiting
600 participants
Started: Nov 30, 2025 · Completed: Mar 1, 2031
1 condition
1 sponsor
0 locations
NCT06243731
A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
N/A
Not yet recruiting
10 participants
Started: Nov 30, 2025 · Completed: Jan 31, 2027
3 conditions
1 sponsor
0 locations
NCT06980480
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
PHASE3
Not yet recruiting
183 participants
Started: Nov 29, 2025 · Completed: Sep 11, 2028
2 conditions
3 sponsors
17 locations
NCT07205718
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
PHASE1/PHASE2
Not yet recruiting
223 participants
Started: Nov 18, 2025 · Completed: Dec 21, 2029
1 condition
1 sponsor
15 locations
NCT07047521
A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults
PHASE3
Not yet recruiting
496 participants
Started: Nov 17, 2025 · Completed: Jul 30, 2027
1 condition
1 sponsor
5 locations
NCT07108283
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
PHASE2
Not yet recruiting
200 participants
Started: Nov 14, 2025 · Completed: Nov 9, 2027
1 condition
1 sponsor
70 locations
NCT07187440
A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease
N/A
Not yet recruiting
200 participants
Started: Nov 7, 2025 · Completed: Nov 30, 2028
1 condition
1 sponsor
18 locations
NCT04563520
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
PHASE3
Recruiting
5 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2026
1 condition
2 sponsors
2 locations
NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
PHASE3
Not yet recruiting
70 participants
Started: Oct 27, 2025 · Completed: Jan 26, 2032
2 conditions
1 sponsor
0 locations
NCT07123350
Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
N/A
Active, not recruiting
120 participants
Started: Oct 16, 2025 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT07129343
A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
PHASE3
Not yet recruiting
20 participants
Started: Oct 12, 2025 · Completed: Nov 25, 2027
1 condition
1 sponsor
0 locations
NCT07204314
A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder
PHASE3
Not yet recruiting
180 participants
Started: Oct 1, 2025 · Completed: Sep 30, 2029
1 condition
1 sponsor
0 locations
NCT07011576
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)
PHASE2
Recruiting
60 participants
Started: Sep 29, 2025 · Completed: Jun 30, 2027
4 conditions
2 sponsors
10 locations
NCT07136077
A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
PHASE2
Active, not recruiting
20 participants
Started: Sep 18, 2025 · Completed: Apr 1, 2028
6 conditions
3 sponsors
1 location
NCT07042685
Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
PHASE2
Not yet recruiting
50 participants
Started: Aug 31, 2025 · Completed: Dec 31, 2029
1 condition
2 sponsors
1 location
NCT06948318
A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
PHASE3
Recruiting
150 participants
Started: Aug 14, 2025 · Completed: Jul 29, 2029
1 condition
1 sponsor
1 location
NCT07111559
Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial
PHASE4
Recruiting
500 participants
Started: Aug 1, 2025 · Completed: Mar 31, 2029
3 conditions
3 sponsors
13 locations
NCT06550882
A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea
N/A
Recruiting
9 participants
Started: Jul 22, 2025 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT06963827
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
PHASE3
Recruiting
347 participants
Started: Jul 15, 2025 · Completed: Jan 14, 2030
1 condition
1 sponsor
40 locations
NCT06973291
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
PHASE3
Recruiting
600 participants
Started: Jul 9, 2025 · Completed: Jul 3, 2026
1 condition
1 sponsor
113 locations
NCT06973304
A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
PHASE3
Recruiting
13 participants
Started: Jun 26, 2025 · Completed: Jul 28, 2027
1 condition
1 sponsor
4 locations
NCT06665035
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers
PHASE3
Recruiting
212 participants
Started: Jun 16, 2025 · Completed: Mar 3, 2030
1 condition
1 sponsor
4 locations
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
PHASE2
Recruiting
183 participants
Started: May 28, 2025 · Completed: Dec 30, 2029
2 conditions
1 sponsor
1 location
NCT06798012
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
PHASE2
Recruiting
36 participants
Started: May 14, 2025 · Completed: Jun 8, 2028
1 condition
1 sponsor
22 locations
NCT06952699
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
PHASE2
Recruiting
40 participants
Started: May 6, 2025 · Completed: Apr 23, 2026
1 condition
1 sponsor
30 locations
NCT06747351
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
PHASE3
Recruiting
59 participants
Started: May 6, 2025 · Completed: Jun 25, 2028
1 condition
2 sponsors
52 locations
NCT06499285
The Efficacy and Safety of Elritercept in Adult Participants With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) With Anemia (RENEW)
PHASE3
Recruiting
225 participants
Started: May 6, 2025 · Completed: May 31, 2032
1 condition
2 sponsors
28 locations
NCT06750731
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
N/A
Recruiting
200 participants
Started: May 5, 2025 · Completed: Sep 30, 2026
3 conditions
2 sponsors
6 locations
NCT06538064
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
N/A
Recruiting
30 participants
Started: Apr 29, 2025 · Completed: Aug 17, 2027
1 condition
1 sponsor
15 locations
NCT06935266
A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults
PHASE1
Recruiting
64 participants
Started: Apr 22, 2025 · Completed: Oct 21, 2025
1 condition
1 sponsor
1 location
NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
PHASE4
Recruiting
400 participants
Started: Mar 27, 2025 · Completed: Jun 1, 2028
2 conditions
1 sponsor
41 locations
NCT06671496
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
PHASE3
Recruiting
600 participants
Started: Mar 10, 2025 · Completed: Jan 26, 2028
1 condition
1 sponsor
123 locations
NCT06843226
A Study in Children and Adolescents on the Effectiveness of Takeda's Licensed Dengue Vaccine TDV Against Hospitalization Due to Dengue Disease
N/A
Recruiting
70,000 participants
Started: Mar 5, 2025 · Completed: Dec 31, 2029
1 condition
1 sponsor
3 locations
NCT06671483
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
PHASE3
Recruiting
1,088 participants
Started: Mar 3, 2025 · Completed: Jan 28, 2028
1 condition
1 sponsor
198 locations
NCT06588868
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
N/A
Recruiting
400 participants
Started: Feb 27, 2025 · Completed: Jul 31, 2026
3 conditions
2 sponsors
18 locations
NCT06722235
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
PHASE3
Recruiting
171 participants
Started: Feb 27, 2025 · Completed: Dec 28, 2027
1 condition
1 sponsor
71 locations
NCT06841705
Early Vedolizumab As First-Line for Immune-Related Colitis Therapy Trial
PHASE2
Not yet recruiting
80 participants
Started: Feb 25, 2025 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT06677892
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium
N/A
Recruiting
75 participants
Started: Feb 24, 2025 · Completed: Sep 1, 2026
1 condition
1 sponsor
9 locations
NCT06787105
Fruquintinib in Patients With Metastatic Colorectal Cancer
N/A
Recruiting
150 participants
Started: Feb 17, 2025 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT06565078
A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants with Primary Immunodeficiency
N/A
Recruiting
100 participants
Started: Feb 17, 2025 · Completed: Jul 31, 2030
1 condition
1 sponsor
1 location
NCT06812078
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
PHASE2
Recruiting
40 participants
Started: Feb 7, 2025 · Completed: Feb 19, 2026
1 condition
1 sponsor
29 locations
NCT06741683
A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan
PHASE2/PHASE3
Active, not recruiting
187 participants
Started: Jan 31, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
5 locations
NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
PHASE3
Recruiting
70 participants
Started: Jan 22, 2025 · Completed: Jun 30, 2027
2 conditions
1 sponsor
57 locations
NCT06562543
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
PHASE4
Recruiting
78 participants
Started: Jan 14, 2025 · Completed: Oct 4, 2027
1 condition
1 sponsor
45 locations
NCT06227910
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
PHASE3
Recruiting
396 participants
Started: Jan 2, 2025 · Completed: Aug 1, 2028
1 condition
1 sponsor
138 locations
NCT06439342
A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections
PHASE3
Recruiting
20 participants
Started: Dec 16, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
12 locations
NCT06317220
Vedolizumab for the Treatment of Collagenous Gastritis
PHASE2
Recruiting
10 participants
Started: Dec 3, 2024 · Completed: Oct 31, 2026
1 condition
3 sponsors
1 location
«
Previous
1
2
3
4
5
Next